TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment

NCT00144417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

433

Enrollment

FED

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Moxifloxacin (with rifampin, pyrazinamide, and ethambutol)
DRUG: isoniazid

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]